-
Company Insights
NewAroCell AB Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our AroCell AB Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. AroCell AB (AroCell), formerly Xi Bao Research AB, is a vitro diagnostics company. It develops and commercializes tests used for the prognosis and monitoring of treatment of cancer. AroCell TK 210 ELISA is a quantitative immunoassay kit for the determination of Thymidine Kinase 1 (TK1) in human blood. The company develops TK 210 ELISA kits for measuring the enzyme TK1...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nilotinib in Acral Lentiginous Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nilotinib in Acral Lentiginous Melanoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nilotinib in Acral Lentiginous Melanoma Drug Details: Nilotinib (Tasigna, AMN107)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pexidartinib Hydrochloride in Sarcomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pexidartinib Hydrochloride in Sarcomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pexidartinib Hydrochloride in Sarcomas Drug Details: Pexidartinib hydrochloride (Turalio) is an...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pexidartinib Hydrochloride in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pexidartinib Hydrochloride in Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pexidartinib Hydrochloride in Peripheral Nerve Sheath Tumor...
-
Product Insights
NewMologic Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Mologic Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Mologic Ltd (Mologic) is a medical device company that designs, develops, manufactures and supplies in vitro diagnostic medical devices. The companys product portfolio include bacterial vaginosis test kit, peritoneal dialysis test, lateral flow kit, desmosine ELISA kit and FMLP ELISA kit. It offers expertise such as clinical research, chemistry, chronic obstructive pulmonary disease, diagnostic development and enzyme free blood glucose,...
-
Product Insights
NewFujirebio Diagnostics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Fujirebio Diagnostics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Fujirebio Diagnostics Inc (FDI), a subsidiary of Fujirebio Inc, is a healthcare diagnostic company that manufactures, markets and develops biomarker assays and in-vitro diagnostic products. The company’s products include OEM custom solutions, manual kits, serum products, multi-constituent controls, EIA kits, and other test kits, among others. Its serum products comprise enzyme conjugate stabilizer, glycated human hemoglobin animal serums, and...
-
Product Insights
NewCo-Diagnostics Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Co-Diagnostics Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit. Its products find application in window period detection in blood screening, viral load for monitoring the success of treatment, and...
-
Product Insights
NewGenedrive Plc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Genedrive Plc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Genedrive Plc (Genedrive) develops and commercializes point-of-need molecular diagnostics platform for the diagnosis of infectious diseases and pathogens. The company develops its products by using its proprietary Polymerase Chain Reaction (PCR) technology which enables rapid nucleic acid amplification and also to detect various sample types which include, sputum, plasma, and buccal swabs. Its major products include Genedrive HCV ID kit;...
-
Product Insights
NewGeneral Biologicals Corp Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our General Biologicals Corp Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. General Biologicals Corp (GBC) is a medical device company that develops and manufactures diagnostics and pharmaceutical products. The company provides in-vitro diagnostic devices. GBC offers liver inspection tools such as test reagents and equipment. GBC’s products include real-time PCR kits and automated system, ELISA kits and automated system, RIA kits, automated pipetting system, antigens, antibodies, and testing and point-of-care...
-
Product Insights
NewLepu Medical Technology (Beijing) Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Lepu Medical Technology (Beijing) Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical technology company. It offers medical devices, pharmaceutical APIs and Covid-19 test products. Its products portfolio includes interventional accessories, coronary stents, dilatation balloon catheters, mechanical heart valves, electrophysiology catheters, occlusion devices, pacemakers, in vitro diagnostic equipment and DSA systems, biomarkers and surgical staplers. The company's Covid-19...